NAD+ 1000MG & RETATRUTIDE : A UNITED KINGDOM UPDATE

The growing interest in NAD+ supplementation, particularly at a substantial dosage of 1g , continues to build within the UK healthcare community. Concurrently, attention is directed toward Retatrutide, a novel GLP-1 analogue being viewed by many as a potential replacement to Tirzepatide. Right no